Non-HDL cholesterol versus Apolipoprotein B in the identification of dyslipidemic phenotypes associated with cardiovascular risk in type 2 diabetic dyslipoproteinemia

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 1, Issue 1, 2007, Pages 29-36

  Ahmad, Jamal ^a   Khan, Abdur Rahman ^a   Ahmed, Faiz ^a   Siddiqui, Sabah ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Apolipoprotein B; Carotid intima media thickness; Non HDL cholesterol; Type 2 diabetes mellitus

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; APOLIPOPROTEIN B; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SULFONYLUREA DERIVATIVE; TRIACYLGLYCEROL;

ADULT; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET THERAPY; DISEASE MARKER; DYSLIPIDEMIA; DYSLIPOPROTEINEMIA; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INTERMETHOD COMPARISON; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 34247890118     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2006.11.002     Document Type: Article

References (38)

1. Turner R.C., Millns H., Neil H.A.W., Stratton I.M., Manley S.E., Mathews D.R., et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus. United Kingdom Prospective-Diabetes Study (UKPDS: 23). BMJ 316 (1998) 823-828
2. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diab Care 24 (2001) 683-689
3. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Export Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
4. Branchi A., Rovellini A., Torri A., and Sommariva D. Accuracy of calculated serum low-density lipoprotein cholesterol for the assessment of coronary heart disease risk in NIDDM patients. Diab Care 21 (1998) 1397-1402
5. Syvanne M., and Taskinen M. Lipids and lipopoteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet 350 Suppl. 1 (1997) 20-23
6. Sniderman A.D., Furberg C.D., Keech A., Roeters van Lennep J.E., Frolich J.J., Jungner I., et al. Apoproteins versus lipids as indices of coronary risk and as targets for statin therapy; analysis of the evidence. Lancet 36 (2003) 777-780
7. Abate N., Vega G.L., and Grundy S.M. Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B100. Atherosclerosis 104 (1993) 159-171
8. Wagner A.M., Perez A., Zapico E., and Ordonez-Llanos J. Non-HDL cholesterol and apolipoprotein B in dyslipidemic classification of type 2 diabetic patients. Diab Care 26 (2003) 2048-2051
9. Salonen R., and Salonen J.T. Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Atherosclerosis 81 (1990) 33-40
10. Blankenhorn D.H., and Hodis N. Arterial imaging and atherosclerosis reversal. Arterioscler Thromb 14 (1994) 17
11. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., and Wolfson S.K. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults-The Cardiovascular Health Study Collaborative Research Group. N Engl Med 340 (1999) 14-22
12. Mckeigne P.M., Miller G.J., and Marmot M.G. Coronary artery disease in South Asians overseas: a review. J Clin Epidemiol 41 (1989) 597-598
13. Balarajan R. Ethnic differences in mortality from ischaemic heart disease in England and Wales. BMJ 302 (1991) 560-564
14. Mather H.M., and Keen H. The Southhall diabetes survey: prevalence of known diabetes in Asians and Europeans. BMJ 291 (1985) 1081-1084
15. Bensen Jt., Li R., Hutchison R.G., Province M.A., and Tyroler H.A. Family history of coronary heart disease and pre-clinical carotid artery atherosclerosis in African Americans and whites. The ARIC Study: Atherosclerosis Risk in Communities Study. Genet Epidemiol 16 (1999) 165-178
16. Mohan V., Ravikumar R., Rani S.S., and Deepa R. Intimal medial thickness of the carotid artery in south Indian diabetic and non-diabetic subjects: The Chennai Urban Population Study (CUPS). Diabetologia 43 (2000) 494-499
17. Ramachandran A., Jali M.V., Mohan V., Snehlata C., and Viswanathan M. High prevalence of diabetes in an urban population South India. BMJ 297 (1988) 587-590
18. Ramachandran A., Snehlata C., Latha E., Satyavani K., and Vijay V. Clustering of cardiovascular risk factors in urban Asian Indians. Diab Care 21 (1998) 967-971
19. WHO. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part I: diagnosis and classification of diabetes mellitus. Geneva: World Health Organisation; 1999.
20. Friedewald W.T., Levy R.I., and Friedrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
21. Contois J.H., McNamara J.R., Lammi-Keefe C.J., Wilson P.W., Massov T., and Schaeffer E. Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin Chem 42 (1996) 515-523
22. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
23. Austin M.A., King M.C., Vranizan K.M., and Krauss R.M. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 82 (1990) 495-506
24. Durrington P.N., Bolton C.H., and Hartog M. Serum and lipoprotein, apolipoprotein levels in normal subjects and with hyperlipoproteinemia. Clin Chem Acta 82 (1978) 151-160
25. Lamarche B., Tchernof A., Moorjani S., Cantin B., Dagenais G.R., Lupien P.J., et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Circulation 95 (1997) 69-75
26. Griffin B.A., Freeman D.J., Tait G.W., Thomson J., Caslake M.J., and Packard C.J. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small dense LDL to coronary heart disease risk. Atherosclerosis 106 (1994) 241-253
27. Sniderman A.D., Scantlebury T., and Cianflone K. Hypertriglyceridemic hyperapoB: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus. Ann Intern Med 135 (2001) 447-459
28. Lamarche B., Moorjani S., Lupien P.J., Cantin B., Bernard P.M., Dagenais G.R., et al. Apolipoprotein A-1 and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec Cardiovascular Study. Circulation 94 (1996) 273-278
29. Kwiterovich P.O., Coresh J., and Bachorik P.S. Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged 50 years) and women (aged 60 years) with coronary artery disease. Am J Cardiol 71 (1993) 631-639
30. Genest Jr. J., McNamara J.R., Ordovas J.M., Jenner J.L., Silberman S.R., Anderson K.M., et al. Lipoprotein cholesterol, apolipoprotein A-1 and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. J Am Coll Cardiol 19 (1992) 792-802
31. Wagner A.M., Perez A., Calvo F., Bonet R., Castellvi A., and Ordonez J. Apolipoprotein (B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients. Diab Care 22 (1999) 812-817
32. Schaefer E.J., Lamon-Fava S., Cohn S.D., Schaefer M.M., Ordovas J.M., Castelli W.P., et al. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J Lipid Res 35 (1994) 779-792
33. Assmann G., and Schulte H. The Prospective Cardiovascular Munster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 116 (1988) 1713-1724
34. Siegel R.D., Cupples A., Schaefer A.J., and Wilson P.W.F. Lipoproteins, apolipoprotein and low density lipoprotein size among diabetics in the Framingham Offspring study. Metabolism 45 (1996) 1267-1272
35. Sniderman A.D., Lamarche B., Tilley J., Secombe D., and Frolich J. Hypertriglyceridemic hyperapoB in type 2 diabetes. Diab Care 25 (2002) 579-582
36. Lamarche B., Despres J.P., Moorjani S., Cantin B., Dagenais G.R., and Lupien P.J. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Quebec Cardiovascular Study). Am J Cardiol 75 (1995) 1189-1195
37. Syvanne M., and Taskinen M. Lipids and lipopoteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet 350 Suppl. 1 (1997) 20-23
38. Campos H., Genest J., Blijlevens E., McNamara J.R., Jenner J.L., Ordovas J.M., et al. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 12 (1992) 187-195